Over-the-Counter Drugs Market to hit $178bn by 2024: Global Market Insights, Inc.
January 03, 2018 02:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Global OTC Drugs Market is estimated to surpass USD 178 billion by 2024; according to a new research report by Global Market Insights....
Innovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal Permeability
December 28, 2017 09:00 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and...
RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.
September 13, 2017 07:00 ET
|
RedHill Biopharma Ltd.
Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI) indicated for adults for the treatment of gastroesophageal reflux...
Innovate Biopharma’s Pediatric Ulcerative Colitis Drug Granted FDA Orphan Designation
September 06, 2017 17:06 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory...
Innovate Biopharmaceuticals Submits Orphan Drug Application to FDA for Pediatric Ulcerative Colitis Indication
July 12, 2017 07:07 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., July 12, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc., a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory...
Innovate Biopharmaceuticals to present progress towards phase 3 celiac disease trials at BIO 2017 Convention
June 06, 2017 08:07 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 06, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, a leader in developing innovative therapies for autoimmune and inflammatory diseases, will present on its phase 3 drug...
A Microbiologist's Approach to Identifying & Avoiding Food Poisoning
February 02, 2016 15:34 ET
|
ARUP Laboratories
SALT LAKE CITY, Feb. 2, 2016 (GLOBE NEWSWIRE) -- Chipotle is in the midst of a restaurant's nightmare, as it contends with the consequences of three major foodborne outbreaks this past year involving...
RedHill Biopharma to Host 2014 Fourth Quarter and Year-End Financial Results Conference Call on February 26, 2015
February 19, 2015 08:00 ET
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel, Feb. 19, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late...
RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares
February 13, 2015 10:18 ET
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel, Feb. 13, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
November 03, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...